AI-generated analysis. Always verify with the original filing.
Medifast, Inc. reported Q4 2025 revenue of $75.1 million and net loss of $18.1 million including a $12.1 million non-cash valuation allowance, with full year 2025 revenue of $385.8 million and net loss of $18.7 million. The company provided Q1 and full year 2026 guidance and highlighted a strong balance sheet with $167.3 million in cash and no debt.
Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On February 17, 2026, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the fou
. Financial Statements and Exhibits. (d) Exhibits. 99.1 Medifast Announces Fourth Quarter and Full Year 2025 Financial Results 104.1 Cover Page Interactive Data
| Metric | Value | Basis |
|---|---|---|
| Revenue | $75.10 | GAAP |
| Gross Profit | $52.10 | GAAP |
| SG&A | $59.90 | GAAP |
| Loss from Operations | $-7.80 | GAAP |
| Net Loss | $-18.10 | GAAP |
| Diluted EPS | $-1.65 | GAAP |